| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/16/2006 | WO2006064372A9 Method for identifying modulators of the activity of ion-channels receptors |
| 11/16/2006 | WO2006060595A3 Reverse two hybrid system for identification of interaction domains |
| 11/16/2006 | WO2006034485A3 Treatment for age-related cognitive decline and other conditions |
| 11/16/2006 | WO2006031370A3 Polypeptide variants with altered effector function |
| 11/16/2006 | WO2006014437A3 Methods and systems for nanoparticle enhancement of signals |
| 11/16/2006 | WO2006009933A3 Cdk9 as modifier of the igf pathway and methods of use |
| 11/16/2006 | WO2006007534A3 System and method for processing results of a complex genetic test |
| 11/16/2006 | WO2005123993A3 Phage microarray profiling of the humoral response to disease |
| 11/16/2006 | WO2005116613A3 Vial presence indicator for vial-bearing rack |
| 11/16/2006 | WO2005113819A3 System and method for smoothing melting curve data |
| 11/16/2006 | WO2005111610A3 Method of assessing the risk of atherosclerosis |
| 11/16/2006 | WO2005104834A3 Pain-associated gene pnpg5 |
| 11/16/2006 | WO2005100995A3 Methods of determining allergen response using microarray imminoassay techinques |
| 11/16/2006 | WO2005081714A3 Use of interfering rna in the production of transgenic animals |
| 11/16/2006 | WO2005032157A3 Interference detection systems and methods |
| 11/16/2006 | WO2005031358A3 Diagnostics and therapeutics for diseases associated with arginyl aminopeptidase rnpep-like (rnpep-like) |
| 11/16/2006 | WO2003087129A3 Immunogenic peptides, and method of identifying same |
| 11/16/2006 | US20060259996 Structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like (tissue differentiation factor) receptors; methods of detecting, preventing, and treating TDF-associated disorders |
| 11/16/2006 | US20060259993 Amidases, nucleic acids encoding them and methods for making and using them |
| 11/16/2006 | US20060259991 Diagnostic and therapeutic use of scn2b protein for neurodegeneraative diseases |
| 11/16/2006 | US20060259990 Diagnostic and therapeutic use of tb2 gene and protein for neurodegenerative diseases |
| 11/16/2006 | US20060259986 Truncated fragments of alpha-synuclein in Lewy Body Disease |
| 11/16/2006 | US20060259874 System, method, and computer software product for linked window interfaces |
| 11/16/2006 | US20060259252 Method for quality assurance of long timber |
| 11/16/2006 | US20060259248 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer |
| 11/16/2006 | US20060259246 Methods for efficiently mining broad data sets for biological markers |
| 11/16/2006 | US20060258931 Switching circuit arrangement comprising an integrated reference electrode and method for producing said switching circuit arrangement |
| 11/16/2006 | US20060258921 Method of analyzing and processing signals |
| 11/16/2006 | US20060258856 Method of isolating nucleic acids from stool samples |
| 11/16/2006 | US20060258848 Human antipneumococcal antibodies from non-human animals |
| 11/16/2006 | US20060258840 Peroxisome proliferator-activated receptor |
| 11/16/2006 | US20060258702 Stabilization of hypoxia inducible factor (HIF) alpha |
| 11/16/2006 | US20060258660 Stabilization of hypoxia inducible factor (HIF) alpha |
| 11/16/2006 | US20060258620 anticancer agents; angiogenesis inhibitors; fatty acid synthase inhibitors |
| 11/16/2006 | US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy |
| 11/16/2006 | US20060258591 Compositions and methods of treating HIV infections |
| 11/16/2006 | US20060258582 Method of treating myelodysplastic syndromes |
| 11/16/2006 | US20060258580 Such as N-acyl/myristoyl-gamma-glucose-diaminopimelic acid dipeptides; for activation of nuclear factor kappa beta; for treatment of inflammatory diseases such as Crohn's disease and asthma; drug screening |
| 11/16/2006 | US20060258564 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines |
| 11/16/2006 | US20060258021 Biocompatible linkers for surface plasmon resonance biosensors |
| 11/16/2006 | US20060258020 Sanitary utensil with functions of immuno-chromatographic test and indication |
| 11/16/2006 | US20060258015 mesoporous silicate having sub-nanosized fine pores comprises an organosilicon functional group containing a phenyl group, or a silanol group, and the organosilicon functional group or the silanol group interacts intermolecularly with a target benzene molecule |
| 11/16/2006 | US20060258014 Calculating the sulfur concentration in gasoline by measuring sulfur stored in exhaust system, dividing by fixed conversion constant of sulfur oxides and mass of gasoline; pollution control |
| 11/16/2006 | US20060258013 Method for estimating the sulfur content in the fuel of an internal combustion engine |
| 11/16/2006 | US20060258012 Cell lysis by heating-cooling process through endothermic reaction |
| 11/16/2006 | US20060258009 Use of non-absorbable fat in determining dietary fat absorption |
| 11/16/2006 | US20060258008 Method for testing the impermeability of components that contain cavities |
| 11/16/2006 | US20060257993 Integration of fluids and reagents into self-contained cartridges containing sensor elements |
| 11/16/2006 | US20060257992 Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems |
| 11/16/2006 | US20060257989 Truncated aggrecanase molecules |
| 11/16/2006 | US20060257971 Antibodies to pro1561 polypeptide |
| 11/16/2006 | US20060257965 Extracellular matrix signalling molecules |
| 11/16/2006 | US20060257958 Magnetically-assisted test strip cartridge and method for using same |
| 11/16/2006 | US20060257957 Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin a complexes in a blood sample |
| 11/16/2006 | US20060257956 Method and device for chemical or biological analysis by a sensor with a monolithic chamber in the form of a multi-microtubular sheaf and a lateral integration measuring transducer |
| 11/16/2006 | US20060257955 Method for detecting escherichia coli |
| 11/16/2006 | US20060257954 At-home cancer test |
| 11/16/2006 | US20060257953 Artificial antibody polypeptides |
| 11/16/2006 | US20060257952 Measurement of caspase-associated recruitment domain (ASC) for early detection or diagnosis of breast cancer |
| 11/16/2006 | US20060257951 Use of protein spee as a marker for breast cancer |
| 11/16/2006 | US20060257950 Use of protein UBC13 as a marker for breast cancer |
| 11/16/2006 | US20060257949 Methods of diagnosing and treating brain tumors |
| 11/16/2006 | US20060257948 determining whether a treatment of a disorder with an HDAC inhibitor is to be started/continued or not by determining the level of histone acetylation in the sample using an antibody capable of binding to acetylated histone |
| 11/16/2006 | US20060257947 Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibdies and other binding agents |
| 11/16/2006 | US20060257946 Serum biomarkers in ischaemic heart disease |
| 11/16/2006 | US20060257945 Methods and apparatus for detecting cardiac injury markers using an acoustic device |
| 11/16/2006 | US20060257944 System and method for automated selection of T-cell epitopes |
| 11/16/2006 | US20060257943 Ischemic biomarkers and their use to predict adverse neurological events from surgery |
| 11/16/2006 | US20060257942 Conducted in living cells, do not require fixation and washing steps inherent in existing immunostaining and related techniques, and permit rapid, non-invasive, direct visualization of protein localization in living cells |
| 11/16/2006 | US20060257941 Integration of fluids and reagents into self-contained cartridges containing particle and membrane sensor elements |
| 11/16/2006 | US20060257940 Transformed Shigella |
| 11/16/2006 | US20060257939 Spatially addressable combinatorial chemical array in cd-rom format |
| 11/16/2006 | US20060257938 Method of screening for drugs that block ligand binding to a lipid binding protein |
| 11/16/2006 | US20060257937 Focused libraries of genetic packages |
| 11/16/2006 | US20060257936 Kit for monitoring glycation profile of K41membrane proteins (CD59); diagnosing vascular disorder |
| 11/16/2006 | US20060257935 Hematopoietic factor production promoter |
| 11/16/2006 | US20060257933 comprises a substrate having a metal layer on its surface, wherein an acetoacetyl group-containing hydrophilic polymer is bound to the metal layer directly or via an intermediate layer; used for surface plasmon resonance biosensors |
| 11/16/2006 | US20060257932 Treatment of Crohn's disease |
| 11/16/2006 | US20060257931 controll by modifying the N-terminal part of ferritin with a peptide which recognizes and binds to portion of the substrate consisting of titanium, heating to decompose the titanium-binding ferritin, arranging inorganic fe2o3 particles on substrate with high accuracy; biosensors or biochips |
| 11/16/2006 | US20060257930 Characterization of IL-17F and IL-17R interactions |
| 11/16/2006 | US20060257929 Method for the rapid taxonomic identification of pathogenic microorganisms and their toxic proteins |
| 11/16/2006 | US20060257928 ANGE gene in atopy |
| 11/16/2006 | US20060257927 Processes for purification of recombinant proteins |
| 11/16/2006 | US20060257926 Immuno-nephelometry of lipoprotein (a) and reagent therefor |
| 11/16/2006 | US20060257923 capable of processing intron-containing eukaryotic genes, and also can carry out post-translational processing steps such as glyclosylation and protein folding |
| 11/16/2006 | US20060257919 Polymer-coated substrates for binding biological molecules |
| 11/16/2006 | US20060257918 Polynucleotide encoding a novel human G-protein coupled receptor variant of the relaxin receptor HGPRBMY5v1, and variants thereof |
| 11/16/2006 | US20060257917 Fluorescent dyes, energy transfer couples and methods |
| 11/16/2006 | US20060257914 Methods of producing interachain fluorophore-quencher FRET-aptamers and assays |
| 11/16/2006 | US20060257913 Genetic polymorphisms associated with myocardial infarction and uses thereof |
| 11/16/2006 | US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders |
| 11/16/2006 | US20060257910 aligning a protein on a surface; immobilization; Preparing solid support comprising immobilized proteins for detecting, measuring, separating and/or assaying DNA or proteins in a sample |
| 11/16/2006 | US20060257908 Method for two- and three-dimensional microassembly of patterns and structures |
| 11/16/2006 | US20060257906 Compositions comprising a library of analytes for detection, quantification and analyses |
| 11/16/2006 | US20060257903 Compositions and methods for diagnosing and treating neuropsychiatric disorders |
| 11/16/2006 | US20060257901 Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy |
| 11/16/2006 | US20060257898 Comparing the level of RNA for isoform 2 of subunit 4 of cytochrome c oxidase in a sample of lung cells with a sample of lung cells that are known not to have cancer; a lower level of the oxidase in the cells indicates the presence of cancer |
| 11/16/2006 | US20060257897 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/16/2006 | US20060257887 Protein -protein interaction detection system using fluorescent protein microdomains |
| 11/16/2006 | US20060257883 Detection and measurement of hematological parameters characterizing cellular blood components |